Details for Patent: 10,154,987
✉ Email this page to a colleague
Which drugs does patent 10,154,987 protect, and when does it expire?
Patent 10,154,987 protects EPANED and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 10,154,987
Title: | Enalapril formulations |
Abstract: | Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction. |
Inventor(s): | Mosher; Gerold L. (Kansas City, MO), Miles; David W. (Kansas City, MO) |
Assignee: | Silvergate Pharmaceuticals, Inc. (Greenwood Village, CO) |
Application Number: | 16/003,994 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,154,987 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,154,987
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | EPANED | enalapril maleate | SOLUTION;ORAL | 208686-001 | Sep 20, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF HYPERTENSION | ⤷ Sign Up | |||
Azurity | EPANED | enalapril maleate | SOLUTION;ORAL | 208686-001 | Sep 20, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION | ⤷ Sign Up | |||
Azurity | EPANED | enalapril maleate | SOLUTION;ORAL | 208686-001 | Sep 20, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING HYPERTENSION | ⤷ Sign Up | |||
Azurity | EPANED | enalapril maleate | SOLUTION;ORAL | 208686-001 | Sep 20, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATMENT OF HEART FAILURE | ⤷ Sign Up | |||
Azurity | EPANED | enalapril maleate | SOLUTION;ORAL | 208686-001 | Sep 20, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF HEART FAILURE | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,154,987
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112018068960 | ⤷ Sign Up | |||
European Patent Office | 3429581 | ⤷ Sign Up | |||
World Intellectual Property Organization (WIPO) | 2017161339 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |